- Research works
- 26 ▲ 208% vs 2013–17
- Citations
- 392 14.8 per fractional work
- Top-10% rate
- 18.2% record average 16.5%
- Open access
- 36% world 28%
Not ranked overall: FutureChem (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Earth and Planetary Sciences, 6.6×. Every wedge is a field page.
Which keywords describe research at FutureChem (South Korea)?
By fractional works in all years, weighted toward what it does more of than the world: Drug Discovery, PET Imaging, Biomarkers, Prostate Cancer, Immunotherapy, Androgen Receptor, Genomic Profiling and Radiopharmaceuticals.
- Protein-Protein Interactions
- Innovation
- Neurodegeneration
- Cancer
- Targeted Therapy
- Genomic Profiling
- Immunotherapy
- Prostate Cancer
- PET Imaging
- Drug Discovery
- Biomarkers
- Climate Change
- Androgen Receptor
- Radiopharmaceuticals
- Green Chemistry
- Catalysis
- Economic Development
- Obesity
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 18 words, with their numbers
- Drug Discovery2▲ 20×7 topics
- PET Imaging2▲ 33×3 topics
- Biomarkers2▲ 11×2 topics
- Prostate Cancer2▲ 44×2 topics
- Climate Change1▲ 2.1×3 topics
- Immunotherapy1▲ 8.3×2 topics
- Androgen Receptor1▲ 55×1 topic
- Genomic Profiling1▲ 51×1 topic
- Radiopharmaceuticals1▲ 120×1 topic
- Targeted Therapy1▲ 22×1 topic
- Green Chemistry1▲ 15×5 topics
- Cancer1▲ 2.9×4 topics
- Catalysis1▲ 5.2×5 topics
- Neurodegeneration1▲ 13×5 topics
- Economic Development1▲ 5.5×1 topic
- Innovation1▲ 4.1×1 topic
- Obesity1▲ 5.1×4 topics
- Protein-Protein Interactions1▲ 36×2 topics
Which research topics does FutureChem (South Korea) publish most on?
By volume in 2022–2025: Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Alzheimer's disease research and treatments and Ocean Waves and Remote Sensing.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 2 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 3 Alzheimer's disease research and treatments Physiology 0 works
- 4 Ocean Waves and Remote Sensing Oceanography 0 works
- 5 Peptidase Inhibition and Analysis Oncology 0 works
- 6 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
- 7 Geotechnical Engineering and Underground Structures Civil and Structural Engineering 0 works
- 8 Wave and Wind Energy Systems Ocean Engineering 0 works
- 9 Coastal and Marine Dynamics Earth-Surface Processes 0 works
- 10 Geotechnical Engineering and Soil Stabilization Civil and Structural Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has FutureChem (South Korea)'s research output changed?
Output in 2018–2022 was 208% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Seoul
- Seoul National University
- Yonsei University
- Korea University
- Sungkyunkwan University
- Hanyang University
- Kyung Hee University
- Chung-Ang University
- Samsung (South Korea)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.